Advances in Sulfonamide Kappa Opioid Receptor Antagonists: Structural Refinement and Evaluation of CNS Clearance | ACS Chemical Neuroscience
Nanobody-enabled monitoring of kappa opioid receptor states | Nature Communications
Identification of the Kappa-Opioid Receptor as a Therapeutic Target for Oligodendrocyte Remyelination | Journal of Neuroscience
Considerations on Using Antibodies for Studying the Dynorphins/Kappa Opioid Receptor System | SpringerLink
Cells | Free Full-Text | Analysis of the Glucose-Dependent Transcriptome in Murine Hypothalamic Cells
Cells | Free Full-Text | Challenges with Methods for Detecting and Studying the Transcription Factor Nuclear Factor Kappa B (NF-κB) in the Central Nervous System
Considerations on Using Antibodies for Studying the Dynorphins/Kappa Opioid Receptor System | SpringerLink
Cardiolipin and OPA1 Team up for Methamphetamine-Induced Locomotor Activity by Promoting Neuronal Mitochondrial Fusion in the Nucleus Accumbens of Mice | ACS Chemical Neuroscience
Topical administration of the kappa opioid receptor agonist nalfurafine suppresses corneal neovascularization and inflammation | Scientific Reports
Parkin-deficient rats are resistant to neurotoxicity of chronic high-dose methamphetamine - ScienceDirect